| __timestamp | ADMA Biologics, Inc. | Arrowhead Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 23138050 |
| Thursday, January 1, 2015 | 7015946 | 57410147 |
| Friday, January 1, 2016 | 7688238 | 41454452 |
| Sunday, January 1, 2017 | 6229587 | 31690298 |
| Monday, January 1, 2018 | 3926120 | 52968505 |
| Tuesday, January 1, 2019 | 2343848 | 81048686 |
| Wednesday, January 1, 2020 | 5907013 | 128874979 |
| Friday, January 1, 2021 | 3646060 | 206342000 |
| Saturday, January 1, 2022 | 3613764 | 297307000 |
| Sunday, January 1, 2023 | 3300000 | 353188000 |
| Monday, January 1, 2024 | 505870000 |
Infusing magic into the data realm
In the ever-evolving world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Arrowhead Pharmaceuticals, Inc. has consistently outpaced ADMA Biologics, Inc. in R&D investment. From 2014 to 2023, Arrowhead's R&D expenses surged by over 1,400%, peaking at $353 million in 2023. In contrast, ADMA's spending saw a decline, dropping by approximately 65% over the same period, with expenditures falling to $3.3 million in 2023. This stark contrast highlights Arrowhead's aggressive pursuit of innovation, while ADMA appears to be more conservative in its R&D approach. The data for 2024 is incomplete, but the trend suggests Arrowhead's continued dominance in R&D investment. As the biotech industry advances, these spending patterns may significantly influence each company's future breakthroughs and market positioning.
Comparing Innovation Spending: Eli Lilly and Company and ADMA Biologics, Inc.
Gilead Sciences, Inc. or ADMA Biologics, Inc.: Who Invests More in Innovation?
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Summit Therapeutics Inc. and ADMA Biologics, Inc. Allocate Funds
Summit Therapeutics Inc. vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
Axsome Therapeutics, Inc. or ADMA Biologics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How ADMA Biologics, Inc. and MiMedx Group, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Arrowhead Pharmaceuticals, Inc. and MannKind Corporation